Thiogenesis Therapeutics, Corp.

TSXV:TTI Stock Report

Market Cap: CA$32.8m

Thiogenesis Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Patrice Rioux

Chief executive officer

CA$139.0k

Total compensation

CEO salary percentage100.0%
CEO tenure2.2yrs
CEO ownership14.8%
Management average tenureno data
Board average tenure2.2yrs

Recent management updates

Recent updates

Here's Why We're Not Too Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Situation

Aug 25
Here's Why We're Not Too Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Situation

We're Not Very Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Rate

May 01
We're Not Very Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Rate

CEO Compensation Analysis

How has Patrice Rioux's remuneration changed compared to Thiogenesis Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CA$5m

Sep 30 2023n/an/a

-CA$3m

Jun 30 2023n/an/a

-CA$3m

Mar 31 2023n/an/a

-CA$3m

Dec 31 2022CA$139kCA$139k

-CA$4m

Compensation vs Market: Patrice's total compensation ($USD101.04K) is below average for companies of similar size in the Canadian market ($USD174.31K).

Compensation vs Earnings: Insufficient data to compare Patrice's compensation with company performance.

CEO

Patrice Rioux (72 yo)

2.2yrs

Tenure

CA$139,014

Compensation

Dr. Patrice P. Rioux, M. D., Ph. D, serves as Chief Executive Officer of Thiogenesis Therapeutics, Corp. & serves as its Director since March 31, 2022. He serves as Advising Acting Chief Medical Officer of...

Board Members

NamePositionTenureCompensationOwnership
Patrice Rioux
CEO & Director2.2yrsCA$139.01k14.81%
CA$ 4.9m
Brook G. Riggins
CFO, Secretary & Director6yrsCA$97.35k2.31%
CA$ 756.0k
Christopher Starr
Independent Chairman2.2yrsno datano data
Vincent Stanton
Member of Scientific Advisory Boardless than a yearno data3.24%
CA$ 1.1m
David Housman
Member of Scientific Advisory Board1.8yrsno datano data
Kim Tsuchimoto
Independent Director2.2yrsno datano data
Miriam Vos
Member of Scientific Advisory Board1.8yrsno datano data
W. Mullally
Independent Director6yrsno data1.92%
CA$ 630.0k
Gregory Enns
Member of Scientific Advisory Board1.8yrsno datano data

2.2yrs

Average Tenure

67yo

Average Age

Experienced Board: TTI's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.